Screening for chronic obstructive pulmonary disease US preventive services task force recommendation statement

JAMA - Journal of the American Medical Association

Volumn 315, Issue 13, 2016, Pages 1372-1377

  Siu, Albert L ^a,b   Bibbins Domingo, Kirsten ^c   Grossman, David C ^d   Davidson, Karina W ^e   Epling, John W ^f   García, Francisco A R ^g   Gillman, Matthew ^h   Kemper, Alex R ⁱ   Krist, Alex H ^j,k   Kurth, Ann E ^l   Landefeld, C Seth ^m   Mangione, Carol M ⁿ   Harper, Diane M ^o   Phillips, William R ^p   Phipps, Maureen G ^q   Pignone, Michael P ^r  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

^e Columbia University ^*  (United States)

^f SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^g Pima County Department of Health   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j Fairfax Family Practice ^*  (United States)

^k VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^l YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF LOUISVILLE   (United States)

^p UNIVERSITY OF WASHINGTON   (United States)

^q BROWN UNIVERSITY   (United States)

^r UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SALBUTAMOL; TIOTROPIUM BROMIDE;

ADULT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EARLY DIAGNOSIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SERVICE; HUMAN; IMMUNIZATION; LUNG FUNCTION TEST; MORBIDITY; MORTALITY RATE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION; SPIROMETRY; UNITED STATES PREVENTIVE SERVICES TASK FORCE; ADVISORY COMMITTEE; AGED; ASYMPTOMATIC DISEASES; HEALTH STATUS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RISK ASSESSMENT; UNITED STATES;

ADULT; ADVISORY COMMITTEES; AGED; ASYMPTOMATIC DISEASES; EARLY DIAGNOSIS; HEALTH STATUS; HUMANS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK ASSESSMENT; SMOKING CESSATION; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84962606688     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.2638     Document Type: Review

References (18)

1. Kochanek KD, Murphy SL, Xu J, Arias E. Mortality in the United States, 2013. NCHS Data Brief. 2014; (178):1-8.
2. Tilert T, Dillon C, Paulose-Ram R, Hnizdo E, Doney B. Estimating the US prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res. 2013;14:103.
3. Guirguis-Blake JM, Senger CA, Webber EM, Mularski R, Whitlock EP. Screening for Chronic Obstructive Pulmonary Disease: A Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 130. Rockville, MD: Agency for Healthcare Research and Quality; 2016. AHRQ Publication 14-05205-EF-1.
4. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance: United States, 1999-2011. Chest. 2013;144(1):284-305.
5. Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults: United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(46):938-943.
6. Guirguis-Blake JM, Senger CA, Webber EM, Mularski RA, Whitlock EP. Screening for chronic obstructive pulmonary disease: evidence report and systematic review for the US Preventive Services Task Force. JAMA. doi:10.1001/jama.2016 .2654.
7. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3):285-295.
8. Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ; COPD Questionnaire Study Group. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129(6): 1531-1539.
9. Yawn BP, Mapel DW, Mannino DM, et al; Lung Function Questionnaire Working Group. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010;5:1-10.
10. Martinez FJ, Raczek AE, Seifer FD, et al; COPD-PS Clinician Working Group. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85-95.
11. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598-600.
12. Risser NL, Belcher DW. Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: a randomized trial. J Gen Intern Med. 1990;5(1):16-22.
13. Kotz D, Wesseling G, Huibers MJ, van Schayck OC. Efficacy of confronting smokers with airflow limitation for smoking cessation. Eur Respir J. 2009;33(4):754-762.
14. Sippel JM, Osborne ML, Bjornson W, Goldberg B, Buist AS. Smoking cessation in primary care clinics. J Gen Intern Med. 1999;14(11):670-676.
15. McClure JB, Ludman EJ, Grothaus L, Pabiniak C, Richards J. Impact of a brief motivational smoking cessation intervention: the Get PHIT randomized controlled trial. Am J Prev Med. 2009;37(2):116-123.
16. Qaseem A, Wilt TJ, Weinberger SE, et al; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
17. Chronic obstructive pulmonary disease in over 16s: NICE guidelines [CG101]. National Institute for Health and Care Excellence. https://www.nice.org .uk/guidance/cg101. Accessed July 22, 2015.
18. Global strategy for diagnosis, management, and prevention of COPD: 2016. Global Initiative for Chronic Obstructive Lung Disease. http://www .goldcopd.org/guidelines-global-strategy-for -diagnosis-management.html. Accessed July 22, 2015.